News Quantified

HOOK – hookipa pharma inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Hookipa Pharma Inc (NASDAQ: HOOK) had its price target lowered by analysts at JMP Securities from $24.00 to $7.00. They now have a "market outperform" rating on the stock.

Hookipa Pharma Inc (NASDAQ: HOOK) had its price target lowered by analysts at Royal Bank of Canada from $50.00 to $48.00. They now have an "outperform" rating on the stock.

HOOKIPA Pharma GAAP EPS of -$1.10, revenue of $4.7M [Seeking Alpha]

HOOKIPA Pharma Reports Third Quarter 2024 Financial Results and Provides Recent Business Updates [Yahoo! Finance]

HOOKIPA Pharma Reports Third Quarter 2024 Financial Results and Provides Recent Business Updates

-7.1%

MISS

-3.7%

BEAT

-2.0%

MISS

Market Outperform

Market Outperform

Market Outperform

Market Outperform

Form 8-K HOOKIPA Pharma Inc. For: Nov 18

Form SC 13G/A HOOKIPA Pharma Inc. Filed by: EcoR1 Capital, LLC

Form 10-Q HOOKIPA Pharma Inc. For: Sep 30

Form 8-K HOOKIPA Pharma Inc. For: Nov 14

Form 8-K HOOKIPA Pharma Inc. For: Aug 27

Top News Gainers

3/24 Hookipa Pharma Inc (NASDAQ: HOOK) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 17.8%

7/11 HOOKIPA Announces FDA Clearance of IND Application for HB-201 Clinical Trial to Treat HPV-Positive Cancers 16.0%

12/23 Form 4 HOOKIPA Pharma Inc. For: Dec 19 Filed by: Matushansky Igor 14.9%

1/23 2 Small-Cap Biotech Stocks to Watch in 2020 [The Motley Fool] 14.5%

3/19 Form S-8 HOOKIPA Pharma Inc. 11.7%

7/17 Hookipa Pharma Inc (NASDAQ: HOOK) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 10.8%

8/29 HOOKIPA Pharma to Present at Upcoming Investor Conferences in September 9.4%

10/15 Hookipa Pharma Inc (NASDAQ: HOOK) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 9.0%

4/24 Form 4 HOOKIPA Pharma Inc. For: Apr 20 Filed by: Kandera Reinhard 8.7%

11/13 Hookipa Pharma Inc (NASDAQ: HOOK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock. 6.8%

Top News Decliners

5/20 HOOKIPA Pharma Reports First Quarter 2019 Financial Results and Recent Business Highlights -12.9%

7/11 Hookipa Pharma jumps 40% after FDA approval of clinical tests [MarketWatch] -12.2%

3/19 Q4/2019 12/31/2019 EPS -0.400 ZacksConsensus -0.430 ActVsEst 0.030 - Beat -10.5%

3/11 Hookipa Pharma Inc (NASDAQ: HOOK) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -9.7%

3/20 Hookipa Pharma Inc (NASDAQ: HOOK) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $8.25 price target on the stock. -8.9%

11/14 Hookipa Pharma Inc (NASDAQ: HOOK) had its price target lowered by analysts at Bank of America Corp from $17.00 to $14.00. They now have a "buy" rating on the stock. -6.9%

4/21 HOOKIPA Pharma Announces Publication of HB-101 Phase 1 Results in The Journal of Infectious Diseases -5.6%

11/4 HOOKIPA Pharma To Report Third Quarter 2019 Financial Results on November 12, 2019 -5.5%

10/1 Hookipa Pharma Inc (NASDAQ: HOOK) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -4.7%

3/10 HOOKIPA Pharma To Report Fourth Quarter and Full Year 2019 Financial Results on Thursday, March 19, 2020 -4.4%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day